PMS-PIMOZIDE 2 MG
PIMOZIDE : 2 MG · DIN 02239829 · PHARMASCIENCE INC
Health Canada status: CANCELLED POST MARKET
What is PMS-PIMOZIDE?
PMS-PIMOZIDE 2 MG contains PIMOZIDE : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02239829, held by PHARMASCIENCE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Jul-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02239829 |
|---|---|
| Brand name | PMS-PIMOZIDE |
| Generic / active ingredient | PIMOZIDE : 2 MG |
| Manufacturer | PHARMASCIENCE INC |
| Strength | 2 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N05AG02 PIMOZIDE |
| AHFS class | 28:16.08.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Jul-2025 |
| Original market date | 2002-10-18 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02239829 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2239829 |
| Brand name | PMS-PIMOZIDE |
| Active ingredient / INN | PIMOZIDE : 2 MG |
| ATC code | N05AG02 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05 |
| AHFS class | 28:16.08.92 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | PHARMASCIENCE INC |
Which pack is which?
| Strength on the label | 2 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code N05AG02 PIMOZIDE. 2 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PIMOZIDE | 2 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02245432 |
| PIMOZIDE | 4 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02245433 |
| ORAP | 2 MG | TABLET | AA PHARMA INC | DORMANT | DIN 00313815 |
| ORAP | 4 MG | TABLET | AA PHARMA INC | DORMANT | DIN 00313823 |
| ORAP TAB 10MG | 10 MG | TABLET | MCNEIL PHARMACEUTICAL, DIVISION OF ORTHO-MCNEIL INC. | CANCELLED POST MARKET | DIN 00573817 |
| PMS-PIMOZIDE | 10 MG | TABLET | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02239831 |
| PMS-PIMOZIDE | 4 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02239830 |
Who else supplies PIMOZIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PIMOZIDE appears in 12 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does PIMOZIDE cost around the world?
PIMOZIDE is listed on 5 national price registers Nexara tracks, across 9 pack listings published on 5 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 2 | 4 | 03 Sep 2026 |
| South Africa | single exit price | 2 | 2 | 01 Sep 2026 |
| Greece | producer price (ex-factory) | 1 | 1 | 03 Sep 2026 |
| Italy | prezzo al pubblico (classe A) | 1 | 1 | 02 Sep 2026 |
| Saudi Arabia | public | 1 | 1 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.